Related Experiment Video
Updated: Jun 17, 2026

Peptide-based Identification of Functional Motifs and their Binding Partners
Published on: June 30, 2013
The pathogenesis of HIV-associated nephropathy
Lewis Kaufman1, Susan E Collins, Paul E Klotman
1Mount Sinai School of Medicine, New York, NY 10029, USA. lewis.kaufman@mssm.edu
HIV-associated nephropathy (HIVAN) is a major cause of kidney failure in HIV-1 patients, characterized by proteinuria and FSGS. Genetic susceptibility, particularly involving MYH9 variants, and viral gene expression contribute to podocyte dysfunction and disease progression.
Area of Science:
- Nephrology
- Virology
- Genetics
Background:
- HIV-associated nephropathy (HIVAN) is a leading cause of end-stage renal disease (ESRD) in HIV-1-seropositive individuals.
- Patients often exhibit heavy proteinuria and chronic renal failure, with characteristic collapsing focal segmental glomerulosclerosis (FSGS) pathology.
- HIVAN pathogenesis involves direct HIV-1 infection of renal epithelial cells in genetically susceptible hosts.
Purpose of the Study:
- To elucidate the genetic and molecular mechanisms underlying HIVAN.
- To identify host factors and signaling pathways dysregulated by HIV-1 infection in the kidneys.
- To explore potential novel therapeutic targets for preventing and treating HIVAN.
Main Methods:
- Review of existing literature on HIVAN pathogenesis, genetics, and molecular mechanisms.
- Analysis of genetic factors, including noncoding variants in podocyte-expressed genes like MYH9.
- Examination of the role of viral genes (e.g., nef, vpr) in podocyte and tubular dysfunction.
Main Results:
- Genetic susceptibility to HIVAN in Black populations is linked to MYH9 gene variants and other unidentified genetic factors.
- HIV-1 viral gene expression (nef, vpr) leads to podocyte and tubular dysfunction.
- Dysregulation of host factors, signaling pathways, and inflammatory mediators by HIV-1 contributes to renal damage.
Conclusions:
- Understanding the genetic and molecular underpinnings of HIVAN is crucial for therapeutic development.
- Targeting identified host factors and signaling pathways offers potential strategies for managing HIVAN.
- Further research into genetic susceptibility and viral-host interactions is needed to combat HIVAN effectively.
Related Concept Videos
Diabetic Nephropathy
Nephrotic Syndrome I : Introduction
Inhibitors of Virion Maturation and Assembly
Acute Kidney Injury II: Pathophysiology
Cryptococcal Meningitis
Encephalitis ll: Pathophysiology
